Harry has posted Charts of the Day video on SRPT at TheTechTrader site, noting: Sarepta Therapeutics, Inc. (SRPT) ran up to 37.70 on Thursday, a new high in our swing-trade target zone, before pulling back to 36.95. Still, it was up 68 cents, or 1.87%, on 1.7 million shares. It looks like this stock isn’t quite done yet. The short-term channel indicates there is more upside, although it did hit the top on Thursday and that may be one reason why it backed off. It may still accelerate at some point to test the spike high back in October when they had the drug approval.